随着我国医疗器械产业的迅猛发展，中国生产制造的医疗器械越来越受到国际医疗市场的关注。新材料、新技术的出现为中国医械快速走出国门，应对国际市场的挑战起着极为重要的推动作用。然而，有业界专家指出，国产医械在可持续发展的创新能力方面仍不足以与外资企业相抗衡。

Along with the rapid development of medical equipment industry,China's manufacturing medical apparatus and instruments more and more get the attention of the international medical market.The new material/The emergence of new technology for China's YiXie quickly out of the country,To deal with the international market challenge plays an extremely important role.however,Industry experts have pointed out that,Domestic YiXie in the sustainable development of the innovation ability is still not enough to compete with foreign enterprises.

　　“尽管目前在医疗器械创新技术上，我国已具备与国际同步发展的研发水平，但在应用上仍不尽人意。”中国医疗器械行业协会副会长姜峰博士日前在成都第68届中国国际医疗器械博览会举办的第二届医疗器械产业创新与共性技术论坛上指出，我国医疗器械产业发展动力强劲，空间巨大，但仍有不足，特别是在创新技术方面没有形成体系，显得“理想很丰满，现实很骨感”。

"Although at present in medical equipment innovation technology,Our country already have and international synchronized development research and development level,But in the application is still unsatisfactory."The China association for medical devices industry vice chairman dr in chengdu JiangFeng before the 68th China international medical equipment fair event of the second annual medical equipment industry innovation and generic technology BBS points out,Chinese medical equipment industry development motive force strong,Space great,But there is still a shortage,Especially in the innovation technology system has not been formed,appear"Ideal are very plentiful,Reality very bone".

　　进口依赖程度仍较高

Import dependence on higher still

　　目前，在国内医疗器械设备市场，外资和合资企业成为主力军，进口产品在中国已经形成销售垄断。不少业界人士普遍反映，在高端医疗器械设备方面，医疗机构通常会优先考虑以采购外资设备为主。某医院常务副院长表示，像CT、MI、核磁共振等，在医疗机构中几乎没有国产产品，基本上被进口产品垄断。

At present,In domestic medical instrument equipment market,Foreign and joint enterprises become the main force,Import products in China has been formed sales monopoly.Many professionals generally reflected,In the high-end medical instrument equipment,Medical institutions will usually preferred to purchase foreign equipment is given priority to.A hospital executive vice dean said,Like CT/MI/Nuclear magnetic resonance (NMr), etc,In the medical institutions almost no domestic products,Basically be imported products monopoly.

　　公开资料显示，我国每年要花数亿美元外汇从国外进口大量医疗设备，国内有近70%的高端医疗器械市场被发达国家公司瓜分，核磁、MR、CT等医疗设备市场主要集中在GE、西门子和飞利浦等外资公司手里。而在我国医用电子产品领域，90%的心电图机市场、80%的中高档监护仪市场、90%的高档多道生理记录仪市场以及60%的睡眠图仪市场均被外国品牌占据，国产产品则主要集中在按摩器具、血压测量仪器等低附加值种类上。

Public data shows,Every year in our country to spend hundreds of millions of dollars in foreign exchange imported from abroad a lot of medical equipment,Domestic nearly 70% of high-end medical equipment market by developed countries company carve-up,Nuclear magnetic/Mr/CT and medical equipment market mainly concentrated in GE/Siemens and philips and other foreign companies hand.But in the our country medical electronic products field,90% of the electrocardiogram machine market/80% of the high-grade monitor market/90% of the high-grade multichannel recor market and 60% of the sleep graph instrument market are foreign brand occupies,Domestic product is mainly concentrated in the massage appliance/Blood pressure measuring instrument and low value-added species.

　　此外，除了输出产品，跨国公司还通过收购国内企业来获得本土市场份额，并在中国成立总部和研究中心，进一步深耕中国市场。今年8月，全球最大的医疗器械公司之一美敦力刚在上海成立除欧洲和美国外第一家创新中心，美敦力表示，创新中心的成立体现了公司“本土化”的决心。而飞利浦也在苏州投资5400万美元打造专为亚太地区基础医疗业务研发与生产的医疗影像基地。

In addition,In addition to output products,Multinational companies also through the acquisition of domestic enterprises to obtain the local market share,And established in China headquarters and research center,Further subsoil China market.August,The world's largest medical equipment company medtronic just one was founded in Shanghai in Europe and in addition to the first a foreign innovation center,Medtronic said,The establishment of the innovation center embodies the company"localization"determination.Philips also in suzhou investment of 54 million dollar designed for the asia-pacific region basic medical business research and development and production of medical image base.

　　姜峰表示：“跨国公司进入中国的产品附加值越来越高，近几年这种趋势特别明显。而且跨国公司不仅将生产研发转移到中国来，还开始有针对性地基于中国市场进行二次开发，国内企业要看到这种转变，必须进行重大改变。”

JiangFeng said:"Multinational companies to enter the Chinese product added value is more and more high,In recent years the trend particularly evident.And multinational company will not only the r&d and production of transfer to China,Also began to pertinently based on Chinese market and secondary development,Domestic enterprises want to see this change,Must be a significant change."

　　事实上，医疗器械行业有两个特点让企业很“纠结”。全球医学创新与资本合作组织中国首席代表陈新表示，一方面，医疗器械行业壁垒很高，但规模往往不大，利润却又很高；另一方面，高利润往往伴随着高风险，医疗器械产业投资回报周期长，从投入到退出的可预见性也是一大问题，高额投入与较长回报周期让许多投资者望而却步。

In fact,Medical equipment industry has two characteristics make enterprise very"ravel".Global medical innovation and capital cooperation organization chief representative of China, Chen xin said,On the one hand,Medical equipment industry high barriers,But the scale is not often,Profit, but very high;On the other hand,High profit often with high risk,Medical equipment industry investment return cycle is long,From into exit predictability is also a big problem,High input and a long return cycle let many investors flinch.

　　在国内企业还在观望的时候，中国医疗器械市场已然成为跨国企业的掘金场，而且，外资还在不断进入。

In domestic enterprises is still in wait-and-see time,China's medical equipment market has become multinational enterprise the nuggets field,and,Foreign investment is still in the constant into.

　　“我国医疗器械产业仍未形成良好的研发创新环境和激励机制，产业发展主要靠市场自我调节，特别是缺少政府的主导和相关扶持政策，导致政府、企业、风投、科研院所、大专院校等资源关系没有协调发展。”陈新表示。

"Chinese medical equipment industry is still not well formed research and development innovation environment and incentive mechanism,Industrial development depend mainly on the market the self-adjustment,Especially the lack of government leading and relevant supporting policies,Caused the government/enterprise/Wind is cast/Research institutes/Colleges and universities, such as resource relationship not coordinated development.", Chen xin said.

　　核心材料发展亟待强化

To strengthen the core material development

　　了解到，大多数业界人士表示，目前中国的医疗器械产品其实已赶上国际水准了，现在仍有差距的往往是高端产品。

To understand,Most practitioners said,At present China's medical equipment products in fact already catch up with the international standard,Now there are still gap is often high-end products.

　　据悉，目前我国在关键介入医学工程器械及材料方面仍主要依赖进口。数据显示，我国骨科医疗器械占医疗器械市场的1/20,2009年骨科医疗器械市场约为100亿元，其中人工关节30亿元（18万例）、内固定器材20亿元、脊柱修复15亿元（20万例）、骨科修复材料15亿元、其他20亿元。特别在支架材料、导管材料、微导丝、微导管等医械和材料上的依赖程度达100%，颅内血管支架和外周血管支架等材料上的依赖程度也高达80%。

It is reported,At present our country key involved in medical engineering equipment and material is still mainly rely on import.Data display,Our country orthopedic medical apparatus and instruments accounted for 1/20 of the medical equipment market,2009 orthopedic medical equipment market is about 10 billion yuan,The artificial joint 3 billion yuan(180000 cases)/Internal fixation devices is 2 billion yuan/Spinal repair 1.5 billion yuan(200000 cases)/Bone repair materials is 1.5 billion yuan/The other 2 billion yuan.Especially in support material/Catheter materials/Micro guide/Micro catheter, etc YiXie and materials depends on the 100%,Intracranial vascular stents and peripheral vascular stents on materials such as dependent on also is as high as 80%.

　　根据相关规划，“十二五”期间，国家将重点研发市场需求量大的药物涂层支架和可吸收支架，减少再狭窄率和血栓的发生率，逐步替代进口产品，整体达到国际先进水平。同时，储备发展全降解支架，“十三五”期间达到与国际先进水平同步，局部领先。

According to relevant planning,"1025"period,Countries will focus on r&d market demand big drug-coated stents and can absorb support,Reduce the restenosis rate and the incidence of thrombosis,Gradually replace imported products,The overall reached the international advanced level.At the same time,Reserve development full degradation support,"1035"Period to the advanced international level synchronization,Local leading.

　　“医疗器械产业是典型的创新驱动、多学科交叉、全球化竞争激烈的战略新兴产业，具有高度的战略性、带动性和成长性，已与制药一起构成了现代医疗体系的两大产业支柱，作为生物医药产业的重要组成部分，其战略地位受到了发达国家的普遍重视，已成为一个国家技术进步和国民经济现代化水平的重要标志。”中国生物医学工程学院理事长、北京航空航天大学生物与医学工程学院院长樊瑜波教授表示，单纯引进外资产品其实并不适宜中国市场，特别是在骨科产品上。

"Medical equipment industry is a typical innovation drive/interdisciplinary/Globalization competitive strategy emerging industry,Highly strategic/DaiDongXing and growth,Already and pharmaceutical together form the modern medical system two big pillar industry,As a biological medicine industry is an important part,Its strategic position by the developed countries is paid great attention to,Has become a national technical progress and the important symbol of the levels of economic modernization."China institute of biomedical engineering/Beijing university of aeronautics and astronautics biological and medical engineering professor, dean of the college of FanYuBo said,Simple introduction of foreign products in fact is not suitable for the Chinese market,Especially in the orthopedic products.

　　据悉，一些进口的骨科器械产品在临床应用中，由于解剖形态与中国人骨骼不匹配，会造成手术操作难度加大，患者由此承担的风险也随之增加，但由于国产产品质量尚不能超越进口产品，不少医疗机构也只能被动接受。

It is reported,Some imported orthopaedic equipment products in the clinical application,Due to anatomical form and Chinese bone don't match,Can cause operation difficulty increase,Patients thus assume risk also will increase,But as a result of domestic product quality is not beyond the imported products,Many medical institutions can only passive to accept.

　　据樊瑜波教授介绍，目前我国血管支架已经被国外公司率先占领市场。2010年我国进行了30万例冠状支架介入手术，使用了近50万个冠状支架，形成了60多亿元人民币市场，需求巨大。而国产研发层面虽然已经能够跟得上国际趋势，但在具体应用层面仍需要资金、技术、政策等整个产业的共同协作努力。

According to FanYuBo introduced professor,At present our country stents have been foreign company takes the lead in occupation of the market.In 2010, 300000 cases of coronary stents intervention operation,Use nearly 500000 coronary stents,Formed more than 60 RMB one hundred million market,Needs huge.And domestic research and development level although have been able to follow the international trend,But in the specific application level still need money/technology/The policy of the whole industry to work together.

　　姜峰也表示，技术创新与金融支持已经成为当今世界各行各业发展不可或缺的必要条件，科技创新战略和金融战略已上升为国家战略。如何走“产学研用”相结合的创新发展之路，并最大限度地利用科技金融对产业的积极推动作用已不仅是单个企业需要重视的问题，更是关系产业兴衰和国家宏观经济发展的核心问题。

JiangFeng also said,Technology innovation and financial support has become the world today all walks of life development indispensable necessary condition,Science and technology innovation strategy and financial strategy has increased as the national strategy.How to go"With the combination of"The combination of innovation development way,And make the best use of technology and finance on the industry actively promote role has is not only a single enterprise needs to pay attention to the problem,Is the rise and fall and national relationship industry of macro economic development core problem.